<DOC>
	<DOCNO>NCT00319605</DOCNO>
	<brief_summary>Phase IV , observational , post-authorization , cross sectional , open-label , multicenter study evaluate acceptability oral solution levetiracetam patient partial epilepsy assess questionnaire .</brief_summary>
	<brief_title>Cross Sectional Study Evaluate Acceptability Oral Solution Levetiracetam</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Patients 16 year old old diagnose partial epilepsy without generalization receive levetiracetam oral solution least 28 day study Patients disturbances sense taste smell interfere assessment parameter study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Cross sectional study</keyword>
	<keyword>acceptability</keyword>
	<keyword>levetiracetam</keyword>
	<keyword>oral solution</keyword>
	<keyword>Keppra</keyword>
</DOC>